DEPLOYMENT OF THE ASTRAZENECA COVID-19 VACCINE IN NORTHERN IRELAND AND UPDATED JCVI ADVICE ON COVID-19 VACCINES

HSS(MD) 93 2020 – DEPLOYMENT OF THE ASTRAZENECA COVID-19 VACCINE IN NORTHERN IRELAND AND UPDATED JCVI ADVICE ON COVID-19 VACCINES
on 30 December the COVID-19 vaccine developed by AstraZeneca/Oxford, was granted approval for use following a thorough review carried out by the Medicines and Healthcare products Regulatory Agency (MHRA). In addition to this announcement the Joint Committee on Vaccination and Immunisation (JCVI) have also issued further updated advice in relation to the COVID-19 vaccination programme.

JCVI have advised that the second dose of the Pfizer-BioNTech vaccine may be given between 3 to 12 weeks following the first dose, and that the second dose of the AstraZeneca (Oxford) vaccine may be given between 4 to 12 weeks following the first dose.

Privacy settings